BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 31870736)

  • 1. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.
    Shan D; Zou L; Liu X; Shen Y; Cai Y; Zhang J
    Am J Obstet Gynecol; 2020 Jun; 222(6):564-579.e12. PubMed ID: 31870736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
    Toulis KA; Tzellos T; Kouvelas D; Goulis DG
    Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
    Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
    JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acupuncture for menopausal hot flushes.
    Dodin S; Blanchet C; Marc I; Ernst E; Wu T; Vaillancourt C; Paquette J; Maunsell E
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007410. PubMed ID: 23897589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of gabapentin for the management of natural or surgical menopausal hot flashes.
    Hayes LP; Carroll DG; Kelley KW
    Ann Pharmacother; 2011 Mar; 45(3):388-94. PubMed ID: 21343402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin for the treatment of hot flushes in menopause: a meta-analysis.
    Yoon SH; Lee JY; Lee C; Lee H; Kim SN
    Menopause; 2020 Apr; 27(4):485-493. PubMed ID: 32049930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise for vasomotor menopausal symptoms.
    Daley A; Stokes-Lampard H; Thomas A; MacArthur C
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006108. PubMed ID: 25431132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
    Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
    Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of preoperative administration of gabapentin/pregabalin in improving pain after total hip arthroplasty: a meta-analysis.
    Mao Y; Wu L; Ding W
    BMC Musculoskelet Disord; 2016 Aug; 17(1):373. PubMed ID: 27577678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-hormonal interventions for hot flushes in women with a history of breast cancer.
    Rada G; Capurro D; Pantoja T; Corbalán J; Moreno G; Letelier LM; Vera C
    Cochrane Database Syst Rev; 2010 Sep; (9):CD004923. PubMed ID: 20824841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial.
    Guttuso T; Kurlan R; McDermott MP; Kieburtz K
    Obstet Gynecol; 2003 Feb; 101(2):337-45. PubMed ID: 12576259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial.
    Vrselja A; Latifi A; Baber RJ; Stuckey BGA; Walker MG; Stearns V; Hickey M; Davis SR
    Lancet; 2022 Nov; 400(10364):1704-1711. PubMed ID: 36366886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis.
    Liu T; Chen S; Mielke GI; McCarthy AL; Bailey TG
    Climacteric; 2022 Dec; 25(6):552-561. PubMed ID: 35904028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions.
    Johns C; Seav SM; Dominick SA; Gorman JR; Li H; Natarajan L; Mao JJ; Irene Su H
    Breast Cancer Res Treat; 2016 Apr; 156(3):415-426. PubMed ID: 27015968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsants for fibromyalgia.
    Üçeyler N; Sommer C; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010782. PubMed ID: 24129853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.
    Taku K; Melby MK; Kronenberg F; Kurzer MS; Messina M
    Menopause; 2012 Jul; 19(7):776-90. PubMed ID: 22433977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytoestrogens for vasomotor menopausal symptoms.
    Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.
    Maclennan AH; Broadbent JL; Lester S; Moore V
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD002978. PubMed ID: 15495039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.